Mepolizumab
Mepolizumab Brand Name– Nucala What is Mepolizumab Mepolizumab is a subcutaneous interleukin (IL)-5 receptor antagonist monoclonal antibody (IgG1, kappa) indicated for add-on maintenance treatment of severe asthma with an eosinophilic phenotype and for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA), which is also known as Churg-Strauss syndrome. Mepolizumab is directed against IL-5, which is …
